Patel says strategic move to capitalize on indigenous research Nirma Group has entered into definitive agreement to acquire 75% of Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited at an enterprise value of about Rs.7,500 crore, expanding its existing presence...
Read moreDetails












